Loss of p27 Nuclear Expression in a Prognostically Favorable Subset of Well-Differentiated Pancreatic Endocrine Neoplasms

American Journal of Clinical Pathology

Volumn 120, Issue 5, 2003, Pages 685-690

  Rahman, Ayman ^a   Maitra, Anirban ^a   Ashfaq, Raheela ^b   Yeo, Charles J ^a   Cameron, John L ^a   Hansel, Donna E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Expression; Lymph node; Metastasis; p27 kip1; Pancreas; Pancreatic endocrine neoplasm; Prognosis

Indexed keywords

PROTEIN P27;

ADULT; ANTIBODY LABELING; ARTICLE; CELL LABELING; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABELING INDEX; LIVER METASTASIS; LYMPH NODE; LYMPH NODE METASTASIS; MALE; NEUROENDOCRINE TUMOR; PANCREATIC ENDOCRINE NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

EID: 0242300585     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/LPJBRGQX95KRY3G3     Document Type: Article

References (32)

1. Gumbs AA, Moore PS, Falconi M, et al. Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol. 2002;81:45-53.
2. Hunter T, Pines J. Cyclins and cancer, II: cyclin D and CDK inhibitors come of age. Cell. 1994;79:573-582.
3. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-1677.
4. Polyak K, Lee MH, Erdjument-Bromage H, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 1994;78:59-66.
5. Matsuoka S, Edwards MC, Bai C, et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995;9:650-662.
6. Xiong Y, Hannon GJ, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature. 1993;366:701-704.
7. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817-825.
8. De Paola F, Vecci AM, Granato AM, et al. p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions. J Pathol. 2002;196:26-31.
9. Chen J, Willingham T, Shuford M, et al. Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1. J Clin Invest. 1996;97:1983-1988.
10. Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 1996;85:733-744.
11. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996;85:707-720.
12. Kiyokawa H, Kineman RD, Manova-Todorova KO, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 1996;85:721-732.
13. Gillett CE, Smith P, Peters G, et al. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma. J Pathol. 1999;187:200-206.
14. Kawana H, Tamaru J, Tanaka T, et al. Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am J Pathol. 1998;153:505-513.
15. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 1997;3:231-234.
16. Masciullo V, Sgambato A, Pacilio C, et al. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res. 1999;59:3790-3794.
17. Singh SP, Lipman J, Goldman H, et al. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 1998;58:1730-1735.
18. Watanabe J, Sato H, Kanai T, et al. Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus: correlation with proliferation and clinicopathological parameters. Br J Cancer. 2002;87:81-85.
19. Kouvaraki M, Gorgoulis VG, Rassidakis GZ, et al. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors. Cancer. 2002;94:2454-2465.
20. Guo SS, Wu X, Shimoide AT, et al. Anomalous overexpression of p27(Kip1) in sporadic pancreatic endocrine tumors. J Surg Res. 2001;96:284-288.
21. 1-phase progression. Genes Dev. 1999;13:1501-1512.
22. Cheng M, Olivier P, Diehl JA, et al. The p21(Cip1) and p27(Kip1) CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 1999;18:1571-1583.
23. 1 arrest. Nat Med. 2002;8:1153-1160.
24. Kip1 at threonine 157 and modulation of its cellular localization. Nat Med. 2002;8:1145-1152.
25. Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med. 2002;8:1136-1144.
26. Lloyd RV, Erickson LA, Jin L, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154:313-323.
27. Ferrando AA, Balbin M, Pendas AM, et al. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas. Hum Genet. 1996;97:91-94.
28. Spirin KS, Simpson JF, Takeuchi S, et al. p27/Kip1 mutation found in breast cancer. Cancer Res. 1996;56:2400-2404.
29. Blain SW, Massague J. Breast cancer banishes p27 from nucleus. Nat Med. 2002;8:1076-1078.
30. Bulotta A, Hui H, Anastasi E, et al. Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1. J Mol Endocrinol. 2002;29:347-360.
31. Zhang SL, Chen X, Wei CC, et al. Insulin inhibits dexamethasone effect on angiotensinogen gene expression and induction of hypertrophy in rat kidney proximal tubular cells in high glucose. Endocrinology. 2002;143:4627-4635.
32. Robker RL, Richards JS. Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol. 1998;12:924-940.